Published in J Phys Condens Matter on July 25, 2013
Topological states and phase transitions in Sb2Te3-GeTe multilayers. Sci Rep (2016) 0.75
Interfacial phase-change memory. Nat Nanotechnol (2011) 2.30
Pancreatic ductal abnormalities documented by secretin-enhanced MRCP in asymptomatic subjects with chronic pancreatic hyperenzymemia. Am J Gastroenterol (2009) 2.10
Distortion-triggered loss of long-range order in solids with bonding energy hierarchy. Nat Chem (2011) 1.45
Asymptomatic versus symptomatic infarcts from vasospasm in patients with subarachnoid hemorrhage: serial magnetic resonance imaging. Neurosurgery (2001) 1.23
Commissioning of a micro multi-leaf collimator and planning system for stereotactic radiosurgery. Radiother Oncol (1999) 1.18
The existence of a new subtype of alpha-adrenoceptor on the rat anococcygeus is revealed by SGD 101/75 and phenoxybenzamine. Br J Pharmacol (1982) 1.16
Structure-activity relationships of 2-(1H-imidazol-1-yl)vinyl ethers. Route to the new broad-spectrum antifungal agent omoconazole. Ann N Y Acad Sci (1988) 1.07
Toward the ultimate limit of phase change in Ge(2)Sb(2)Te(5). Nano Lett (2010) 1.01
Phagocytosis of wear debris by osteoblasts affects differentiation and local factor production in a manner dependent on particle composition. Biomaterials (2000) 0.96
Efficacy of neuroendoscopic procedures in minimally invasive preferential management of pineal region tumors: a prospective study. J Neurosurg (2000) 0.94
Intrinsic fluorescence and quenching effects in photoactivated reactively sputtered silver oxide layers. J Am Chem Soc (2001) 0.94
Pressure-induced site-selective disordering of Ge2Sb2Te5: a new insight into phase-change optical recording. Phys Rev Lett (2006) 0.93
Investigation on localized states in GaN nanowires. ACS Nano (2008) 0.91
Uranium and thorium in soils, mineral sands, water and food samples in a tin mining area in Nigeria with elevated activity. J Environ Radioact (2009) 0.90
Results of early surgical evacuation of packed intraventricular hemorrhage from aneurysm rupture in patients with poor-grade subarachnoid hemorrhage. J Neurosurg (1999) 0.87
Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach. Radiat Prot Dosimetry (2009) 0.86
[The physical and technical outlook for neutron therapy in Germany]. Strahlenther Onkol (1993) 0.84
Initial structure memory of pressure-induced changes in the phase-change memory alloy Ge2Sb2Te5. Phys Rev Lett (2009) 0.84
The confounding effects of intraoral metals in salivary biomarkers. Occup Environ Med (2007) 0.83
Diagnostic yield of ERCP and secretin-enhanced MRCP and EUS in patients with acute recurrent pancreatitis of unknown aetiology. Dig Liver Dis (2009) 0.82
Electrical spin injection into InN semiconductor nanowires. Nano Lett (2012) 0.82
Measurements of daily urinary uranium excretion in German peacekeeping personnel and residents of the Kosovo region to assess potential intakes of depleted uranium (DU). Sci Total Environ (2007) 0.81
Radiation Dose to Patients from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used Substances. Ann ICRP (2015) 0.81
Focal hepatic glycogenosis. Int J Oncol (1997) 0.81
The use of a symptom checklist (SCL-90-R) as an easy method to estimate the relapse risk after alcoholism detoxification. Eur Addict Res (2002) 0.81
Electrical transport properties of single undoped and n-type doped InN nanowires. Nanotechnology (2009) 0.80
Pharmacological and toxicological studies of binodaline hydrochloride. Arzneimittelforschung (1983) 0.80
Assessment of intestinal absorption of trace metals in humans by means of stable isotopes. Isotopes Environ Health Stud (2002) 0.79
Selective-area catalyst-free MBE growth of GaN nanowires using a patterned oxide layer. Nanotechnology (2011) 0.79
Fast neutron therapy in treatment of soft tissue sarcoma--the Berlin-Buch study. Bull Cancer Radiother (1996) 0.79
1-amino-3-phenylindoles with antidepressant activity. Binodaline hydrochloride and related substances. Arzneimittelforschung (1980) 0.79
Internal biokinetic behaviour of molybdenum in humans studied with stable isotopes as tracers. Isotopes Environ Health Stud (2000) 0.78
Multiple state transport deduced by weak antilocalization and electron-electron interaction effects in Sb(x)Te(1-x) layers. J Phys Condens Matter (2014) 0.78
New calculations for internal dosimetry of beta-emitting radiopharmaceuticals. Radiat Prot Dosimetry (2010) 0.78
Daily uranium excretion in German peacekeeping personnel serving on the Balkans compared to ICRP model prediction. Radiat Prot Dosimetry (2007) 0.78
Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer. The 10-year results of a prospective phase II trial. Strahlenther Onkol (2013) 0.77
[Beclobrate and eniclobrate hydrochloride, new diphenylmethane derivatives as agents for lowering cholesterol and triglyceride levels. Part I: Synthesis and consideration of structure-activity relationships (author's transl)]. Arzneimittelforschung (1979) 0.76
Determination of dose rates from natural radionuclides in dental materials. J Environ Radioact (2006) 0.76
[Venous paradoxical air embolism]. Anaesthesist (1999) 0.76
[Wet dog shake behavior in normal rates, elicited by benzylideneaminooxycarbonic acid derivatives]. Psychopharmacologia (1976) 0.76
[Bariatric surgery - significance, risks, long term consequences]. MMW Fortschr Med (2013) 0.76
[Complications in cerebral angiography. A study of 6698 cerebral angiographies]. Rev Med Chir Soc Med Nat Iasi (1992) 0.75
Comment on "New structural picture of the Ge2Sb2Te5 phase-change alloy". Phys Rev Lett (2012) 0.75
Development, implementation and quality assurance of biokinetic models within CONRAD. Radiat Prot Dosimetry (2008) 0.75
Doping concentration of GaN nanowires determined by opto-electrical measurements. Nano Lett (2008) 0.75
Enhanced light scattering of the forbidden longitudinal optical phonon mode studied by micro-Raman spectroscopy on single InN nanowires. Nanotechnology (2010) 0.75
New developments in internal dosimetry models. Radiat Prot Dosimetry (2010) 0.75
Acoustic charge transport in GaN nanowires. Nanotechnology (2008) 0.75
[Our experience with sodium methohexital in obstetrics]. Minerva Anestesiol (1969) 0.75
Observation of changes in urinary excretion of thorium in humans following ingestion of a therapeutic soil. J Environ Radioact (2007) 0.75
A methodology for biokinetic studies using stable isotopes: results of repeated molybdenum investigations on a healthy volunteer. Appl Radiat Isot (1997) 0.75
Isothermal decay studies of intermediate energy levels in quartz. Radiat Environ Biophys (2004) 0.75
Minimising activity and dose with enhanced image quality by radiopharmaceutical administrations. Radiat Prot Dosimetry (2010) 0.75
[Comparison of gamma-phenylpropylcarbamate and urethane in a carcinogen test in mice]. Arzneimittelforschung (1966) 0.75
Long-term outcome of right split in situ grafts in adults. Transplant Proc (2005) 0.75
Post-deposition annealing of praseodymia films on Si(111) at low temperatures. J Phys Condens Matter (2011) 0.75
A re-evaluation of the biokinetics of zirconium in humans. Appl Radiat Isot (2003) 0.75
The work of the CONRAD task group 5.2: research studies on biokinetic models. Radiat Prot Dosimetry (2007) 0.75
[Testing of dimetacrine and azapropazone in a carcinogen test on mice]. Arzneimittelforschung (1969) 0.75
[Pharmacokinetic studies on azapropazone in animals]. Arzneimittelforschung (1973) 0.75
[Pharmacologic studies on the enteral effects of the quarternary ammonium salt dipenine bromide and on its contribution to the effect of a gastro-therapeutic agent]. Arzneimittelforschung (1965) 0.75
Internal dosimetry: towards harmonisation and coordination of research. Radiat Prot Dosimetry (2008) 0.75
Nuclear detecting systems at LNL and LNS: foreseen experiments to provide basic data for heavy-ion risk assessment. Phys Med (2001) 0.75
[Studies on the resorption and metabolism of gamma-phenylpropyl carbamate (Phenprobamate)]. Arzneimittelforschung (1966) 0.75
Biokinetic studies in humans with stable isotopes as tracers. Part 2: Uptake of molybdenum from aqueous solutions and labelled foodstuffs. Isotopes Environ Health Stud (1998) 0.75
Raman scattering study of GaN nanostructures obtained by bottom-up and top-down approaches. J Phys Condens Matter (2006) 0.75
Current path in light emitting diodes based on nanowire ensembles. Nanotechnology (2012) 0.75
The use of alpha-Al2O3:C in Risø OSL single grains attachment system for assessing the spatial dose rate distribution due to incorporation of 90Sr in human teeth. Radiat Prot Dosimetry (2006) 0.75
Influence of the administered mass of tellurium on plasma clearance in rabbits. Appl Radiat Isot (1995) 0.75
EURADOS coordinated action on research, quality assurance and training of internal dose assessments. Radiat Prot Dosimetry (2010) 0.75
[On the toxicology of the quaternary ammonium compound alpha, alpha-dicyclopentyl-acetic acid -diathylamino-ethylester-bromoctylate (Ug 767)]. Arzneimittelforschung (1968) 0.75
Measurement techniques for tracer kinetic studies with stable isotopes of zirconium. Radiat Prot Dosimetry (2007) 0.75
[Pancuronium bromide. Our experiences in abdominal surgery]. Minerva Anestesiol (1973) 0.75
Proton activation analysis of stable isotopes for a molybdenum biokinetics study in humans. Med Phys (1995) 0.75
Kinetics of systemic ruthenium in human blood using a stable tracer. J Radiol Prot (2001) 0.75
Stable tracer investigations in humans for assessing the biokinetics of ruthenium and zirconium radionuclides. Radiat Prot Dosimetry (2003) 0.75
[Studies on the pharmacology of dimethyl sulfoxide (DMSO)]. Arch Int Pharmacodyn Ther (1966) 0.75
[Psychologic rehabilitation of hospitalized old people by satisfying their basic needs]. G Gerontol (1970) 0.75
[Pharmacological effects of 9,9-dimethyl-10-dimethylaminopropyl acridane bitartrate (SD 709)]. Wien Klin Wochenschr (1966) 0.75
Coordination of research on internal dosimetry in Europe: the CONRAD project. Radiat Prot Dosimetry (2007) 0.75
Regional dependence of urinary uranium baseline levels in non-exposed subjects with particular reference to volunteers from Northern Italy. J Environ Radioact (2003) 0.75
A biokinetic model for systemic technetium in adult humans. J Radiol Prot (2015) 0.75
Properties of uniform diameter InN nanowires obtained under Si doping. Nanotechnology (2011) 0.75
[Pharmacological and toxicological testing of new anti-inflammatory agent azapropazon=3-dimethylamine-7-methyl-1,2-(n-propylmalonyl)-1,2-dihydro-1,2,4-benzotriazine]. Arzneimittelforschung (1969) 0.75
ICRP Publication 134: Occupational Intakes of Radionuclides: Part 2. Ann ICRP (2016) 0.75
[Studies on the resorption and metabolism of the antidepressant 9,9-dimethyl-10-(3-dimethyl-aminopropyl)-acridan-hydrogen tartrate]. Arzneimittelforschung (1968) 0.75
Giant dipole resonance in the hot and thermalized 132Ce nucleus: damping of collective modes at finite temperature. Phys Rev Lett (2006) 0.75
Investigation of biokinetics of radioiodine with a population kinetics approach. Radiat Prot Dosimetry (2010) 0.75
[Cytostatic antiphlogistics. II. Antimicrobial activity range and comparison in the Oedipus test]. Arzneimittelforschung (1970) 0.75
Influence of the chemical form on the plasma clearance of ruthenium in humans. Appl Radiat Isot (2004) 0.75
Inventory and geochemical host phases of natural radionuclides in tin mining materials from Nigeria. Appl Radiat Isot (2009) 0.75
Determination of biokinetic parameters for ingestion of radionuclides of zirconium in animals using stable tracers. Radiat Environ Biophys (2000) 0.75
Limits of thermoluminescence dosimetry using quartz extracted from recent building materials in urban settlements. J Environ Radioact (2005) 0.75
Longer InN phonon lifetimes in nanowires. Nanotechnology (2012) 0.75
Sensitivity analysis techniques applied to a revised model of molybdenum biokinetics. Radiat Prot Dosimetry (2003) 0.75
Use of charged particle activation as an analytical technique in the biological field. Appl Radiat Isot (1998) 0.75
[Antitremor effects of diethylaminoethyl-diphenylcarbamate hydrochloride]. Arzneimittelforschung (1965) 0.75